A fter occlusion of a coronary artery, an area corresponding to the perfusion territory of that artery becomes ischemic and will become infarcted unless timely reperfusion occurs. [1] [2] [3] [4] [5] [6] This area is known as the myocardium at risk (MaR), and it can be used to calculate myocardial salvage index, 7 which is currently used as an end point in at least 19 ongoing clinical trials (Appendix I in the Data Supplement).
Extent of Myocardium at Risk
Earlier attempts to measure the coronary perfusion territories have relied on animal studies or anatomic studies, such as dissections and casts of the vasculature in autopsy studies. 8, 9 More recently, the advent of perfusion imaging, such as by myocardial perfusion single-photon emission computed tomography (MPS), [10] [11] [12] [13] [14] [15] and tissue characterization by cardiovascular magnetic resonance (CMR) 7, [16] [17] [18] [19] has allowed for visualization of MaR directly. However, only 2 MPS studies with a limited number of patients have looked at the extent of perfusion territories. 20, 21 Where MPS uses injection of a radioactive perfusion tracer during occlusion to image relative perfusion, CMR imaging uses pulse sequences that are sensitive to tissue properties in postischemic myocardium, such as contrast-enhanced steady state free precession (CE-SSFP) 18, 19 and T2-weighted short tau inversion recovery (T2-STIR). 17, 18 Although both MPS and CMR are used for imaging of MaR, CMR offers higher spatial resolution and provides an accurate anatomic representation of the heart making it ideally suited for visualization of the MaR and thus the coronary perfusion territories.
Knowledge of the perfusion territories and the size of the perfusion defect associated with different arteries is important when designing clinical trials using myocardial salvage index as end point. In addition, computer models for automatically analyzing and delineating myocardium, MaR, and infarct for CMR and MPS often use a priori information about the extent of perfusion territories. 22, 23 Such models are becoming increasingly important both for research and for clinical practice. The perfusion territories have also been of interest for electrocardiography research where effort has been made trying to predict position and extent of the myocardial injury from an ECG. [24] [25] [26] Thus, the aim of this study is to quantify and to visualize the extent of the perfusion territories for the 3 main coronary arteries, left anterior descending artery (LAD), left circumflex artery (LCx), and right coronary artery (RCA), using CE-SSFP and T2-STIR CMR sequences and to provide data on perfusion territories to be used for simulation and programming.
Methods

Study Population and Design
The CHILL-MI 27 and MITOCARE 28 studies were approved by the regional ethics committees, and all patients provided written informed consent to participate in the respective study. Patients from these 2 multicenter cardioprotection trials underwent CMR imaging within 2 to 6 days after being diagnosed with acute myocardial infarction and treated with primary percutaneous coronary intervention. 27 Inclusion and exclusion criteria for each of the clinical trials have been previously published. 27, 29 In short, all patients had clinical signs of acute myocardial infarction defined as clinical symptoms and ECG signs consistent with ST-segment-elevation myocardial infarction or new left bundle branch block, were ≥ 18 years old, and had symptom duration of <6 hours. Patients with previous infarction or history of coronary revascularization were excluded.
Coronary Angiography
For the CHILL-MI trial, the culprit lesion and Rentrop grade was estimated by an angiography core laboratory. 27 For the MITOCARE trial, Rentrop grade and culprit lesion was estimated and documented by the interventionist performing the coronary intervention at the respective site using the coronary angiogram information together with clinical data, such as ECG changes. 29
CMR Image Acquisition
All CMR examinations were performed on a 1.5 T system from either Philips (Philips Healthcare, Best, The Netherlands), Siemens (Siemens AG, Erlangen, Germany), or General Electrics (GE Healthcare, Fairfield). All subjects were placed in a supine position, and images were acquired at end-expiratory breath hold with ECG gating. Initial scout images were acquired to locate the heart. For MaR visualization, a triple inversion recovery T2-STIR black blood sequence was applied before administration of the contrast agent. In addition, a multislice multiphase SSFP sequence was applied ≈5 minutes after intravenous administration of a gadolinium-based extracellular contrast agent (0.2 mmol/kg). Both the T2-STIR and the contrast-enhanced SSFP images were acquired in the short-axis view covering the left ventricle (LV) from base to apex. The slice thickness was 8 mm with no slice gap, and the in-plane resolution was typically 1.5×1.5 mm. The temporal resolution of the CE-SSFP images was 20 to 30 frames per cardiac cycle.
For infarct visualization, long-and short-axis late gadolinium enhancement (LGE) images covering the LV from base to apex were Figure 1 . Cardiovascular magnetic resonance images of myocardium at risk (MaR) and infarct. The MaR by contrast-enhanced steady state free precession (CE-SSFP) and T2-weighted short tau inversion recovery (T2-STIR) are shown on the top and middle rows and infarct size by late gadolinium enhancement (LGE) on the bottom row in corresponding levels of the left ventricle. All images are from the same patient who underwent reperfusion following occlusion in the left anterior descending artery. MaR by CE-SSFP: 29% of left ventricular mass, MaR by T2-STIR: 28%, and infarct size by LGE: 7%. The epicardium is traced in green and the endocardium in red, whereas MaR is traced in white and infarct in yellow. Extent of Myocardium at Risk acquired ≈15 minutes after injection of gadolinium. The LGE images were acquired using an inversion-recovery gradient-recalled echo sequence with a slice thickness of 8 mm with no slice gap. In-plane resolution was typically 1.5×1.5 mm. Inversion time was adjusted to null the signal from viable myocardium. 30 
CMR Analysis
All CMR images were analyzed by a core laboratory (Imacor AB, Lund, Sweden) using the software Segment, version 1.9 R3314 (http:// segment.heiberg.se). 31 The myocardium in each LV short-axis slice was manually analyzed by delineating the LV epicardial and endocardial borders. Regions of MaR were defined as hyperintense regions within the myocardium on the T2-STIR and CE-SSFP images and were delineated manually. CE-SSFP images were delineated in both end-diastole and end-systole as previously described. 18 The size of MaR was expressed as a percentage of the total LV myocardial volume.
Infarction was delineated from the short-axis LGE images according to a previously described method that has been validated both experimentally and clinically. 32 In short, the endocardial and epicardial borders were traced manually with exclusion of the papillary muscles, and the LGE myocardium was quantified using a computer algorithm taking partial volume effects into account when estimating the amount of infarction. Manual adjustments were made when image artifacts caused misinterpretation by the computer algorithm. If present, a hypointense signal within the area of LGE (microvascular obstruction 33 ) was included in the analysis as 100% infarction. Finally, the myocardial infarct size was expressed as a percentage of the total LV myocardial volume. All delineations were performed by 1 observer with a second opinion with respect to the delineations in each case. In case of disagreement, differences were resolved by reaching consensus via a third expert observer.
Polar Plot Representation of Coronary Artery Distribution
Delineations of MaR from T2-STIR and CE-SSFP short-axis images and infarction from LGE short-axis images were represented as polar plots. The plots were created by resampling each stack to 20 slices, with each slice divided into 80 zones. Each zone was assigned a signal intensity proportional to how frequently MaR or infarction was present in the different patients. This was done for each culprit artery separately. The polar plots were then divided into the 17-segment model of the heart recommended by American Heart Association. 34 Patient images were aligned by marking the right ventricular insertion points in all short-axis slices with a visible right ventricular lumen. The LV was then rotated so that the average position of the right ventricular insertion points was aligned with the border between segments 2 and 3 of the 17-segment model.
Comparison With Previous MPS Studies
Data were compared with those from previous MPS studies published by Persson et al 20 and Pereztol-Valdés et al. 21 Because the ranges and SDs of extent of MaR were not published in the article by Persson et al, 20 the lead author was contacted and kindly supplied the data.
Statistical Analysis
The size of MaR for each vessel was presented as mean±SD. A linear mixed model was used to assess differences of MaR and infarct size between the different vessels and for comparing infarct size, MaR by CE-SSFP and MaR by T2-STIR. The correlation between infarct 
Results
Study Population
Of 215 patients, 39% had LAD occlusion, 49% had RCA occlusion, and 12% had LCx occlusion by angiography. As described in previous work, MR and angiography agreed in assigning culprit artery in 97% of patients by CE-SSFP and 89% by T2-STIR. 35 Figure 1 shows an example of CE-SSFP, T2-STIR, and LGE images taken from 1 patient. Eleven CE-SSFP data sets were excluded from MaR analysis because of incomplete image acquisition. An additional 2 CE-SSFP data sets were excluded because of inability to define MaR. Also, 86 T2-STIR data sets were excluded: 15 because of inadequate image acquisition and 71 because of inability to define MaR. Table 1 shows comparisons of patients with diagnostic versus nondiagnostic T2-STIR.
Distribution of MaR
The perfusion territories for each of the 3 main coronary arteries divided into the 17-segment model are shown in Figure 2 , overlayed with isocontour lines in Figure 3 , and compared with LGE to show myocardial salvage in Figure 4 . Detailed data on the distributions are provided in Appendix II in the Data Supplement. The extent of the 3 coronary arteries together is shown in Figure 5 . The overlap between perfusion territories was mainly between LCx and RCA including segments 4, 5, 10, 11, and 15. Average sizes and ranges of MaR are given in Table 2 . MaR size by both CE-SSFP and T2-STIR was greater for LAD than for both RCA and LCx (P<0.001). No statistically significant difference in MaR size was found between RCA and LCx by CE-SSFP (P=0.606) or by T2-STIR (P=0.226). There was no statistically significant difference in MaR by CE-SSFP and by T2-STIR (P=0.674).
Infarct Size
Of 215 data sets, LGE was diagnostic in 190. In data sets with nondiagnostic LGE, the LGE was excluded from further analysis, whereas CE-SSFP and T2-STIR were still included (if diagnostic). The average sizes of infarctions are given in Table 2 . Infarct size was greater for LAD than for both RCA and LCx (P<0.001), whereas there was no statistically significant difference in infarct size between RCA and LCx (P=0.206). Average infarct size was significantly smaller than MaR for all 3 vessels (P<0.001) and for all vessels grouped together (P<0.001). All patients had larger MaR than infarct size using CE-SSFP and all but one when using T2-STIR imaging ( Figure 6 ).
Discussion
This is the first study to give a representative picture of the coronary perfusion territories using CMR.
Coronary Perfusion Territories
In 2008, Ortiz-Pérez et al 36 used LGE imaging to map the distribution of infarct in 93 patients. The present study uses MaR instead and may, therefore, more accurately visualize the true perfusion territories of the coronary arteries. The location and spatial extent of MaR found in the present study are similar to the location and the extent of local perfusion loss found in previous studies using MPS 20, 21 (Figure 7) . The overlap found between the RCA and the LCx perfusion territories (segments 4, 5, 10, 11, and 15) is similar to what was found by Pereztol-Valdés et al 21 and Persson et al. 20 When comparing average size of coronary perfusion territories, however, both the RCA and the LCx sizes were smaller in the Pereztol-Valdés et al 21 and Persson et al 20 MPS studies compared with both CE-SSFP and T2-STIR in the present study ( Table 2) . A possible explanation for this difference is that the patients in the MPS studies were treated electively for chronic coronary stenosis in contrast to the patients in the present study who all presented with first-time acute coronary occlusion. The likelihood of collateral flow influencing the results may, therefore, be less in the present study because, in cases with chronic stenosis, collaterals might have been developed that decrease the amount of myocardium affected by ischemia on occlusion. This is reflected by the low ratio of patients with high Rentrop grade ( Table 3) . Another explanation may be that the plaques that tend to cause chronic stenosis have been shown to be located more distally in the coronary arteries when compared with the unstable plaques causing acute coronary occlusion. 37 In the present study, segments 1, 2, and 3 were only involved in MaR to a limited extent ( Figure 5 ). Segments 1, 2, and 3 partly represent the fibrous part of the basal septum not being a part of MaR. Furthermore, segments 1 and 2 should be supplied by either the left main or the proximal LAD, and none of the patients in this study had left main occlusion.
CMR for MaR
Both T2-STIR and CE-SSFP have earlier been validated against MPS for the detection of MaR. 17, 19 In this study, the extent of the coronary perfusion territories is similar using T2-STIR, CE-SSFP, and MPS. Note that T2-STIR, CE-SSFP, and MPS use different principles for imaging MaR. MPS uses a radioactive isotope, which binds to viable mitochondria and which needs to be administered during occlusion of a coronary vessel, whereas T2-STIR and CE-SSFP are thought to be sensitive to edema generated within the MaR. The similar results obtained by 2 different mechanisms increase the confidence that these methods accurately depict MaR. Some controversy still exists around both T2-STIR imaging and CE-SSFP for depicting MaR. [38] [39] [40] There has been some debate whether CE-SSFP and T2-STIR may actually depict infarction instead of MaR and if MaR may be overestimated using these 2 CMR techniques. 40 However, the results shown herein compare nicely with MPS findings and make it more likely that the 2 CMR techniques depict MaR accurately. Moreover, in the present study, infarct size was smaller than MaR in all data sets (except for one of the Values are expressed as mean±SD (min-max). CE-SSFP indicates contrastenhanced steady state free precession; CMR, cardiovascular magnetic resonance; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; and T2-STIR, T2-weighted short tau inversion recovery. Extent of Myocardium at Risk T2-STIR images), and significant differences were found between MaR and infarct size for all 3 coronary vessel groups indicating that it is unlikely that the hyperenhanced myocardium, seen on both T2-STIR imaging and CE-SSFP, represents only infarction. The findings are consistent with previous findings on the relation between MaR by CE-SSFP and infarct size. 18, 19 Furthermore, the coronary artery overlap found in the present study occurred in parts of the myocardium congruent with previous MPS studies. 20, 21 A significant number of data sets acquired using T2-STIR was considered to be of nondiagnostic quality, which may limit its utility in multicenter, multivendor settings as recently shown. 35 
Limitations
The findings in the present study should be interpreted in the context of some limitations. Apart from CMR, no other method was used to estimate MaR, which means that there is no reference standard to compare with the CE-SSFP or T2-STIR imaging in the present study. Instead, reference is made to previously published studies. 17, 19 Manual delineation was used to estimate MaR both for CE-SSFP and for T2-STIR, which may introduce observer dependence in MaR quantification. However, automatic methods that rely on a fixed number of standard deviations from remote myocardium are not applicable in a multicenter setting with different signal:noise ratio in images from different centers and scanners. 41 Although this study used Figure 7 . Polar plots, comparison between cardiovascular magnetic resonance (CMR) and myocardial perfusion single-photon emission computed tomography (MPS). The first and second rows show contrast-enhanced steady state free precession (CE-SSFP) and T2-weighted short tau inversion recovery (T2-STIR) images from the present study. The third row shows maximal extent of perfusion territories using MPS (Pereztol-Valdés et al 21 ). The fourth row shows perfusion territories also using MPS (Persson et al 20 ). The left column shows left anterior descending artery (LAD), the middle column right coronary artery (RCA), and the right column left circumflex coronary artery (LCx). The intensity of the plot is proportional to the fraction of patients with myocardium at risk in that area. Extent of Myocardium at Risk right ventricular insertions as reference points for rotation of the heart the MPS studies by Persson et al 20 and Pereztol-Valdés et al 21 used an algorithm commonly applied in the MPS software. 42 The difference in methods used is a limitation when comparing the results; however, the epicenters of MaR using CMR correspond well with those using MPS (Figure 7) , which indicates that this may not be a significant limitation.
Conclusion
The present study has shown the coronary perfusion territories for the 3 main coronary arteries LAD, RCA, and LCx using CE-SSFP and T2-STIR. The agreement with MPS, which acts by a different mechanism, makes it likely that these 3 methods depict MaR accurately. CE-SSFP indicates contrast-enhanced steady state free precession; CMR, cardiovascular magnetic resonance; cTnT, fourth-generation cardiac troponin T; hsTnT, high-sensitivity troponin T; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; and T2-STIR, T2-weighted short tau inversion recovery.
*Patients in the MITOCARE trial. †Patients in the CHILL-MI trial.
